Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The purpose of this study is to determine if TAK-442, once daily (QD) or twice daily (BID), is as safe and effective as enoxaparin in preventing the development of blood clots after knee replacement surgery.
Epistemonikos ID: 403fe7a82a9d13634a60cfdba684273af82a93be
First added on: May 04, 2024